WCI
검색
Login
Sign Up
Sitemap
About Us
Message from the President
Mission
History
Charter
Bylaws
Organization
Linkage with Other Organizations
Membership
Membership
Organization Members
Individual Members
Student Members
Honorary Members
ICI
ICI History
ICI Chronicles
ICI Documents
ICI Photos
Publications
Newsletters
Brochures
Annual Activity Reports
Minutes
Advisory Report
Training /Seminar
Training Courses
Materials
Communication
Announcements
Events
Q&A
RI Related News
RI Related News
Awards
Awards
Winners
Funding
Kinds of WCI funding
Acknowledgements
RI Related News
RI Related News
Home > RI Related News > RI Related News
RI Related News
LOGIN
게시글 목록
No
TItle
Name
Date
Hit
832
Clarity Enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
WCI Secretariat
2025/07/17
506
831
Isotopia and Cardirad Announce Launch of Isoprotrace® in Sweden and Denmark, Expanding Access to Advanced Prostate Cancer Imaging
WCI Secretariat
2025/07/17
488
830
Isotopia and ASP Isotopes Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
WCI Secretariat
2025/07/17
518
829
ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope
WCI Secretariat
2025/07/17
514
828
Laurentis Energy Partners to Produce two Powerful Cancer-Fighting Isotopes Yttrium-90 (Y-90) and Lutetium-177 (Lu-177) in CANDU Nuclear Power Reactors
WCI Secretariat
2025/07/17
480
827
Korea Establishes Domestic Production of Actinium for Prostate Cancer Treatment
WCI Secretariat
2025/07/17
550
826
IBA Launches CASSY®, a New Compact Radiochemistry Module to Enhance Efficiency in Radiopharmaceuticals Production
WCI Secretariat
2025/06/20
496
825
Canadian Nuclear Laboratories and Isowater sign strategic partnership agreement to expand heavy water production
WCI Secretariat
2025/06/20
538
824
Registrational Phase III AMPLIFY trial in biochemical recurrence of prostate cancer commences
WCI Secretariat
2025/06/20
477
823
Curium Receives Marketing Authorization in Switzerland for PYLCLARI® – a 18F-PSMA PET Tracer Indicated in Patients with Prostate Cancer
WCI Secretariat
2025/06/20
490
822
SHINE Technologies Announces Plan to Acquire Lantheus’ SPECT Division, Expanding Market Reach and Leadership in Nuclear Medicine
WCI Secretariat
2025/06/20
523
821
Telix’s Illuccix PSMA-PET Imaging Agent Approved in France
WCI Secretariat
2025/06/20
529
820
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee (DSMC)
WCI Secretariat
2025/06/20
481
819
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis
WCI Secretariat
2025/06/20
502
818
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177
WCI Secretariat
2025/06/20
502
First
Prev
1
2
3
4
5
6
7
8
9
10
Next
End (61 Page)
Name
Title
Contents
비밀글입니다!
글작성시 입력했던 비밀번호를 입력해주세요.
비밀번호 입력